Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RAMALINGAM, Suresh")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 31

  • Page / 2
Export

Selection :

  • and

Maintenance Therapy in Nonsmall-Cell Lung Cancer: A New Treatment ParadigmMOK, Tony S. K; RAMALINGAM, Suresh S.Cancer. 2009, Vol 115, Num 22, pp 5143-5154, issn 0008-543X, 12 p.Article

ALK-Positive Non-Small Cell Lung Cancer: Mechanisms of Resistance and Emerging Treatment OptionsSTEUER, Conor E; RAMALINGAM, Suresh S.Cancer. 2014, Vol 120, Num 16, pp 2392-2402, issn 0008-543X, 11 p.Article

Gene expression profiling of Non-small cell lung cancerSINGHAL, Sunil; MILLER, Daniel; RAMALINGAM, Suresh et al.Lung cancer. 2008, Vol 60, Num 3, pp 313-324, issn 0169-5002, 12 p.Article

Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging ConsensusOWONIKOKO, Taofeek K; RAMALINGAM, Suresh S; BELANI, Chandra P et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2496-2504, issn 1078-0432, 9 p.Article

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non―Small Cell Lung CancerSOCINSKI, Mark A; GOLDMAN, Jonathan; BONOMI, Philip et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 3068-3077, issn 1078-0432, 10 p.Article

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced MalignanciesZAMBONI, William C; RAMALINGAM, Suresh; FRIEDLAND, David M et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1466-1472, issn 1078-0432, 7 p.Article

Significance of EGFR protein expression and gene amplification in non-small cell lung carcinomaDACIC, Sanja; FLANAGAN, Melina; CIEPLY, Kathleen et al.American journal of clinical pathology. 2006, Vol 125, Num 6, pp 860-865, issn 0002-9173, 6 p.Article

A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serumPARISE, Robert A; HOLLERAN, Julianne L; BEUMER, Jan H et al.Journal of chromatography. B. 2006, Vol 840, Num 2, pp 108-115, issn 1570-0232, 8 p.Article

Phase 2 Study of Irinotecan and Paclitaxel in Patients With Recurrent or Refractory Small Cell Lung CancerRAMALINGAM, Suresh S; FOSTER, Judy; GOODING, William et al.Cancer. 2010, Vol 116, Num 5, pp 1344-1349, issn 0008-543X, 6 p.Article

Adenoid Cystic Carcinoma of the Head and Neck: Incidence and Survival Trends Based on 1973-2007 Surveillance, Epidemiology, and End Results DataELLINGTON, Christopher L; GOODMAN, Michael; BEITLER, Jonathan J et al.Cancer. 2012, Vol 118, Num 18, pp 4444-4451, issn 0008-543X, 8 p.Article

Diallyl Trisulfide Selectively Causes Bax-and Bak-Mediated Apoptosis in Human Lung Cancer CellsDONG XIAO; YAN ZENG; HAHM, Eun-Ryeong et al.Environmental and molecular mutagenesis (Print). 2009, Vol 50, Num 3, pp 201-212, issn 0893-6692, 12 p.Article

Radiosurgery for the treatment of spinal lung metastasesGERSZTEN, Peter C; BURTON, Steven A; BELANI, Chandra P et al.Cancer. 2006, Vol 107, Num 11, pp 2653-2661, issn 0008-543X, 9 p.Article

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAREGBE, Abdulateef O; SHERER, Eric A; EGORIN, Merrill J et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 201-205, issn 0344-5704, 5 p.Article

Effect of the CYP3A Inhibitor Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Advanced Solid Tumors: A Prospective, Multicenter, Open-Label, Randomized, Two-Way Crossover Drug-Drug Interaction StudyVENKATAKRISHNAN, Karthik; RADER, Michael; NEUWIRTH, Rachel et al.Clinical therapeutics. 2009, Vol 31, Num THEM, pp 2444-2458, issn 0149-2918, 15 p., 2Article

Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non-Small-Cell Lung CancerBELANI, Chandra P; RAMALINGAM, Suresh; PERRY, Michael C et al.Journal of clinical oncology. 2008, Vol 26, Num 3, pp 468-473, issn 0732-183X, 6 p.Article

Outcomes for Elderly, Advanced-Stage Non-Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel : Analysis of Eastern Cooperative Oncology Group Trial 4599RAMALINGAM, Suresh S; DAHLBERG, Suzanne E; LANGER, Corey J et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 60-65, issn 0732-183X, 6 p.Article

E5501: phase II study of topotecan sequenced with etoposide/ cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancerOWONIKOKO, Taofeek K; AISNER, Joseph; XIN VICTORIA WANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 171-180, issn 0344-5704, 10 p.Article

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid TumorsRAMANATHAN, Ramesh K; EGORIN, Merrill J; ERLICHMAN, Charles et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1520-1526, issn 0732-183X, 7 p.Article

Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): A systematic reviewBEHERA, Madhusmita; OWONIKOKO, Taofeek K; SUNGJIN KIM et al.Oral oncology (1997). 2014, Vol 50, Num 9, pp 888-894, issn 1368-8375, 7 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung CancerRAMALINGAM, Suresh S; HARVEY, R. Donald; HAIAN FU et al.Cancer. 2010, Vol 116, Num 16, pp 3903-3909, issn 0008-543X, 7 p.Article

Class I HDACs Are Mediators of Smoke Carcinogen-Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung CancerBRODIE, Seth A; GE LI; VERTINO, Paula M et al.Cancer prevention research (Philadelphia, Pa.). 2014, Vol 7, Num 3, pp 351-361, issn 1940-6207, 11 p.Article

Long-Term Use of Valproic Acid in US Veterans Is Associated With a Reduced Risk of Smoking-Related Cases of Head and Neck CancerHYUNSEOK KANG; GILLESPIE, Theresa W; GOODMAN, Michael et al.Cancer. 2014, Vol 120, Num 9, pp 1394-1400, issn 0008-543X, 7 p.Article

Human Immunodeficiency Virus-Associated Lung Cancer in the Era of Highly Active Antiretroviral TherapyPAKKALA, Suchita; ZHENGJIA CHEN; RAMALINGAM, Suresh S et al.Cancer. 2012, Vol 118, Num 1, pp 164-172, issn 0008-543X, 9 p.Article

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; MAITLAND, Michael L; BELANI, Chandra P et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 56-62, issn 0732-183X, 7 p.Article

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung CancerRAMALINGAM, Suresh S; SPIGEL, David R; LIAN LIU et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4574-4580, issn 0732-183X, 7 p.Article

  • Page / 2